MedTrace Logo

Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment Outcomes

NCT01690754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2207

Last updated 2015-03-20

No results posted yet for this study

Summary

In this study, Interactive Research and Development (IRD) in Karachi, Pakistan is evaluating the impact of Interactive Reminders on drug compliance and treatment outcomes. Interactive Reminders is an interactive SMS reminder system to help patients remember to take their TB medication. In this system, patients receive daily SMS reminders for the duration of their treatment at a pre-specified time, reminding them to take their medication. Patients are asked to reply back to the system, either through SMS or a missed call, with the time they took their medicine that day. If a response is not received within two hours, a second reminder is sent. If a response is still not received in a further two hours, a third and final reminder for the day is sent. Non-responsive patients are followed up with phone calls and a list of non-responsive patients is shared with clinics based on the parameters of non-responsiveness that they specify.

IRD seeks to determine the impact of this system on treatment outcomes and compliance to prescribed medication through administering a randomized control trial among newly diagnosed TB patients in Karachi, Pakistan.

Conditions

Interventions

OTHER

Interactive Reminders

Daily SMS reminders sent to TB patients at a pre-specified time. They are asked to respond to the reminders. If a response is not received within two hours, they are sent another reminder for up to three per day.

Sponsors & Collaborators

Principal Investigators

  • Rachel Glennerster, PhD. · Massachusetts Institute of Technology

  • Shama Mohammed, MPA/ID · Interactive Research and Development

  • Aamir J. Khan, MD/PhD. · Interactive Research and Development

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01690754 on ClinicalTrials.gov